Long-term effects of nicotine on the forced swimming test in mice: An experimental model for the study of depression caused by smoke

[1]  Y. Kitamura,et al.  Influence of imipramine on the duration of immobility in chronic forced-swim-stressed rats. , 2004, Acta medica Okayama.

[2]  S. Saravay,et al.  Smoking and depression. , 2004, The Medical clinics of North America.

[3]  F. Firenzuoli,et al.  Hypericum perforatum attenuates nicotine withdrawal signs in mice , 2003, Psychopharmacology.

[4]  A. Fernández-Guasti,et al.  Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test , 2003, Neuropsychopharmacology.

[5]  C. Flachskamm,et al.  Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin‐releasing hormone receptor‐dependent mechanism , 2002, The European journal of neuroscience.

[6]  E. Tatarczyńska,et al.  Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. , 2002, Polish journal of pharmacology.

[7]  S. File,et al.  Mood differences between male and female light smokers and nonsmokers , 2002, Pharmacology Biochemistry and Behavior.

[8]  Peter Olausson,et al.  Involvement of serotonin in nicotine dependence: Processes relevant to positive and negative regulation of drug intake , 2002, Pharmacology Biochemistry and Behavior.

[9]  P. Kenny,et al.  Neurobiology of the nicotine withdrawal syndrome , 2001, Pharmacology Biochemistry and Behavior.

[10]  S. Houle,et al.  Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. , 2001, The American journal of psychiatry.

[11]  P. Celada,et al.  How does pindolol improve antidepressant action? , 2001, Trends in pharmacological sciences.

[12]  D. David,et al.  Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? , 2001, Behavioural Brain Research.

[13]  S. File,et al.  Nicotine regulates 5‐HT1A receptor gene expression in the cerebral cortex and dorsal hippocampus , 2001, The European journal of neuroscience.

[14]  F. Squadrito,et al.  Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. , 2001, Pharmacopsychiatry.

[15]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[16]  D. Balfour,et al.  The Effects of Nicotine on Neural Pathways Implicated in Depression A Factor in Nicotine Addiction? , 2000, Pharmacology Biochemistry and Behavior.

[17]  B. Leonard,et al.  5‐HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response , 2000, Human psychopharmacology.

[18]  M. Reuben,et al.  Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes , 2000, Neuropharmacology.

[19]  R. Isola,et al.  Nicotine abstinence in the mouse , 1999, Brain Research.

[20]  L. Covey.  Tobacco cessation among patients with depression. , 1999, Primary care.

[21]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[22]  Trevor R. Norman,et al.  Onset of the Effects of the 5-HT1A Antagonist, WAY-100635, Alone, and in Combination With Paroxetine, on Olfactory Bulbectomy and 8-OH-DPAT–Induced Changes in the Rat , 1999, Pharmacology Biochemistry and Behavior.

[23]  G. Koob,et al.  Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.

[24]  A. Glassman,et al.  Cigarette smoking and major depression. , 1998, Journal of addictive diseases.

[25]  N. Harada,et al.  Neurotransmitter‐Mediated Regulation of Brain Aromatase: Protein Kinase C‐ and G‐Dependent Induction , 1996, Journal of neurochemistry.

[26]  R. Salín-Pascual,et al.  Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. , 1996, The Journal of clinical psychiatry.

[27]  F. Artigas,et al.  Role of 5‐HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies , 1996, Fundamental & clinical pharmacology.

[28]  Michael Rickels,et al.  Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.

[29]  F. Squadrito,et al.  Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[30]  W K Bickel,et al.  Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. , 1994, Addiction.

[31]  R. Wurtman,et al.  Effects of systemic nicotine on serotonin release in rat brain , 1993, Brain Research.

[32]  S. Peroutka.  5‐Hydroxytryptamine Receptors , 1993, Journal of neurochemistry.

[33]  D. Cucinotta,et al.  Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. , 1993, European journal of pharmacology.

[34]  S. Peroutka,et al.  5‐Hydroxytryptamine receptor “families” , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  R. Porsolt,et al.  Behavioural despair in rats: a new model sensitive to antidepressant treatments. , 1978, European journal of pharmacology.

[36]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[37]  M. Jarvis,et al.  The scientific case that nicotine is addictive , 2005, Psychopharmacology.